Transaction · 0001193125-26-412653

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS LP, DIR, reported a transaction classified as grant at INCYTE CORP involving 322.000000 shares for an estimated $0.00. Reported holdings after the transaction were 28206082.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
INCYINCYTE CORP
Filing timeOct 02
Trade dateSep 30, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$115.30
Pre-filing
1mo ago +6.9%1w ago +8.1%1d ago +6.9%
Returns since
7d30d90d180d1y

INCY price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
INCY since 2026-10-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001193125-26-412653
Common Stock
Transaction date
Sep 30, 2026
Filed Oct 02, 2026, 09:54 PM · 2d delay
Shares
322 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
28.2M sh
Indirect · See Footnotes
-18score
Filing-only score

-18

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    Includes 322 shares of common stock ("Common Stock") of Incyte Corporation (the "Issuer") issued to Julian C. Baker pursuant to the Issuer's Amended and Restated 2010 Stock Incentive Plan (the "Stock…

  2. F2

    After giving effect to the transaction reported herein and as a result of their ownership interest in (i) Baker Biotech Capital, L.P. and (ii) 667, Julian C. Baker and Felix J. Baker each may be deeme…

  3. F3

    Baker Bros. Advisors LP (the "Adviser") serves as the investment adviser to the Funds. In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that…

  4. F4

    Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds or for the benefit of the Funds except to the extent of their…

  5. F5

    Includes beneficial ownership of 15,505 shares of Common Stock previously issued to Julian C. Baker pursuant to the Stock Incentive Plan in lieu of director retainer fees, 14,722 shares of Common Stoc…

  6. F6

    Pursuant to the policies of the Adviser, Julian C. Baker does not have a right to any of the Issuer's securities issued as compensation for his service on the Board, and the Funds are entitled to an i…

  7. such securities. The Funds each own an indirect proportionate pecuniary interest in such securities. Solely as a result of their ownership interest in (i) the general partners of the Funds and (ii) th…

  8. may be deemed to have an indirect pecuniary interest in the shares of Common Stock, Stock Options, Common Stock issued upon exercise of Stock Options, RSUs and Common Stock received upon vesting of RS…

  9. F7

    Pursuant to the policies of the Adviser, the Adviser has voting and dispositive power over the Common Stock received in lieu of director retainer fees, Stock Options, RSUs and any Common Stock receive…

  10. F8

    The acquisitions of RSUs reported on this form represent a single grant of 322 RSUs on Table I. The 322 RSUs are reported for each of the Funds as each has an indirect pecuniary interest in such secur…

  11. F9

    After giving effect to the transaction reported herein and as a result of their ownership interest in (i) Baker Brothers Life Sciences Capital, L.P. and (ii) Life Sciences, Julian C. Baker and Felix J…

  12. F10

    Common Stock directly held by Julian C. Baker, a managing member of the Adviser GP.

  13. F11

    Common Stock directly held by Felix J. Baker, a managing member of the Adviser GP.

  14. F12

    Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in 33,410 shares of Common Stock directly held by FBB Associates. Julian C. Baker and Felix J. Baker are the sol…

Original filing · 0001193125-26-412653
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

INCY